These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 4984445)
1. [Study of in vitro and in vivo activity of gentamicin on mycobacterium tuberculosis]. Arnaud R; Audurier A; Morel MF Rev Tuberc Pneumol (Paris); 1967 Dec; 31(8):1176-82. PubMed ID: 4984445 [No Abstract] [Full Text] [Related]
2. [In vitro and in vivo tuberculostatic effects of gentamicin on Mycobacterium tuberculosis]. Sula L; Sulová J; Spurná M; Jedlicková Z; Bárová V Cas Lek Cesk; 1970 Apr; 109(17):369-75. PubMed ID: 4986208 [No Abstract] [Full Text] [Related]
3. ["In vitro" activity of gentamicin on some gram-negative and gram-positive strains and on mycobacterium strains]. Velluti G; Valentini L G Ital Chemioter; 1969; 16(1):74-82. PubMed ID: 4998312 [No Abstract] [Full Text] [Related]
5. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
6. In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis. Martins M; Schelz Z; Martins A; Molnar J; Hajös G; Riedl Z; Viveiros M; Yalcin I; Aki-Sener E; Amaral L Int J Antimicrob Agents; 2007 Mar; 29(3):338-40. PubMed ID: 17239569 [TBL] [Abstract][Full Text] [Related]
7. [Tuberculostatic activity of various rifampicin derivatives in vitro and in vivo]. Kochanova NK; Miakotina EN; Bellendir EN; Boiarkina SK; Iudelevich VI Probl Tuberk; 1983 Jun; (6):65-8. PubMed ID: 6410375 [No Abstract] [Full Text] [Related]
8. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo]. Belogurova VP; Gorislavets II; Ivanitskaia NN Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746 [No Abstract] [Full Text] [Related]
9. [Comparison of in-vitro and in-vivo activities of enoxacin and ofloxacin against the Mycobacterium tuberculosis]. Xu G; Li H; Liu S Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):175-7, 192. PubMed ID: 8565090 [TBL] [Abstract][Full Text] [Related]
10. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of Mycobacterium fortuitum and M. chelonei to sisomicin, gentamicin and tobramycin. Casal MJ; Rodriguez FC Ann Microbiol (Paris); 1983; 134B(3):451-4. PubMed ID: 6675495 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis. Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013 [TBL] [Abstract][Full Text] [Related]
13. [Antimycobacterial activity of a dry birch bark extract on a model of experimental pulmonary tuberculosis]. Demikhova OV; Balakshin VV; Presnova GA; Bocharova IV; Lepekha LN; Chernousova LN; Smirnova TG; Pospelov LE; Chistiakov AN Probl Tuberk Bolezn Legk; 2006; (1):55-7. PubMed ID: 16512188 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria. Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491 [No Abstract] [Full Text] [Related]
15. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo. Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635 [TBL] [Abstract][Full Text] [Related]
16. [In vivo and in vitro experimental research on polyresistant Mycobacterium tuberculosis]. Daddi G; Lucchesi M; Mancini P; Matzeu M; Termine A Ann Ist Carlo Forlanini; 1969; 29(4):301-16. PubMed ID: 5004329 [No Abstract] [Full Text] [Related]
17. [In vivo & in vitro effects of ristocetin on Mycobacterium tuberculosis]. SPINA G; CASSANO A; STORNIELLO G; NUZZOLO L Ann Ist Carlo Forlanini; 1958; 18(4):409-30. PubMed ID: 13650412 [No Abstract] [Full Text] [Related]
18. In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA. Dutta NK; Mazumdar K; Dastidar SG; Chakrabarty AN; Shirataki Y; Motohashi N In Vivo; 2005; 19(3):539-45. PubMed ID: 15875773 [TBL] [Abstract][Full Text] [Related]
20. [Effect of vitamin K on the development of Mycobacterium tuberculosis in vitro and in vivo]. Navarrete BE Rev Latinoam Microbiol; 1971; 13(1):41-4. PubMed ID: 4996460 [No Abstract] [Full Text] [Related] [Next] [New Search]